Literature DB >> 1457186

The dilemma of AIDS vaccine and therapy. Possible clues from comparative pathogenesis with measles.

M R Hilleman.   

Abstract

AIDS viruses, because of their unique properties, are extraordinary. Past successes achieved with vaccines against ordinary viruses do not provide the guidelines needed to develop successful vaccines against HIV. Neither vaccines nor drugs can be relied upon to provide an answer to AIDS. AIDS is a disease of immune dysfunction and destruction, and an alternative to prevention of infection or cure might lie with elimination of the clinical consequences of infection. This might find a basis in precise definition of its pathogenesis. The enormity of possible pathogenetic changes in HIV infection invites simplification, and might be aided by a search for clues among ordinary viruses in which there is a less complicated biology and spontaneous recovery from infection. Measles virus infection presents analogies to AIDS, especially in the induction of anergy and increased mortality, in the long term, from diseases other than measles as observed in children infected during early life. This was demonstrated recently in increased deaths, all causes, during a three-year period among infants who were given live measles virus vaccine of high infectivity titer during early infancy, sometimes in the presence of maternal antibody. AIDS and measles may be diseases of similar pathogenesis, but with the difference that AIDS immunopathology is progressive while that for measles is regressive.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1457186     DOI: 10.1089/aid.1992.8.1743

Source DB:  PubMed          Journal:  AIDS Res Hum Retroviruses        ISSN: 0889-2229            Impact factor:   2.205


  2 in total

1.  Mice chronically infected with chimeric HIV resist peripheral and brain superinfection: a model of protective immunity to HIV.

Authors:  Jennifer L Kelschenbach; Manisha Saini; Eran Hadas; Chao-Jiang Gu; Wei Chao; Galina Bentsman; Jessie P Hong; Tomas Hanke; Leroy R Sharer; Mary Jane Potash; David J Volsky
Journal:  J Neuroimmune Pharmacol       Date:  2011-10-11       Impact factor: 4.147

2.  A proposal for a new approach to a preventive vaccine against human immunodeficiency virus type 1.

Authors:  H M Temin
Journal:  Proc Natl Acad Sci U S A       Date:  1993-05-15       Impact factor: 11.205

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.